Mucopolysaccharidosis type I: molecular characteristics of two novel alpha-L-iduronidase mutations in Tunisian patients

[1]  S. Laradi,et al.  Molecular analysis of iduronate -2- sulfatase gene in Tunisian patients with mucopolysaccharidosis type II , 2011, Diagnostic pathology.

[2]  S. Laradi,et al.  Molecular analysis of mucopolysaccharidosis type I in Tunisia: identification of novel mutation and eight Novel polymorphisms , 2011, Diagnostic pathology.

[3]  S. Laradi,et al.  Polymorphisms in Tunisian patients with N-acetylgalactosamine-6-sulfate sulfatase gene deficiency: Implication in Morquio A disease , 2011, Diagnostic pathology.

[4]  E. Fateen,et al.  Mutational Analysis of the alpha-L-iduronidase gene in three Egyptian families: identification of three novel mutations and five novel polymorphisms. , 2009, Genetic testing and molecular biomarkers.

[5]  H. Azzouz,et al.  Incidence of mucopolysaccharidoses in Tunisia. , 2009, La Tunisie medicale.

[6]  S. Khedhiri,et al.  La mucopolysaccharidose de type I : identification des mutations du gène alpha-L-iduronidase dans des familles tunisiennes , 2007 .

[7]  S. Laradi,et al.  [Mucopolysaccharidosis type I: identification of alpha-L-iduronidase mutations in Tunisian families]. , 2007, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

[8]  R. Desnick,et al.  Mucopolysaccharidosis I: α-L-Iduronidase mutations in three Tunisian families , 2005, Journal of Inherited Metabolic Disease.

[9]  S. Withers,et al.  A homology model for human α-l-iduronidase: Insights into human disease , 2005 .

[10]  Višnja Petković,et al.  Prvi rezultati primjene nadomjesne enzimske terapije u dvoje bolesnika s mukopolisaharidozom IH , 2005 .

[11]  S. Withers,et al.  A homology model for human alpha-l-iduronidase: insights into human disease. , 2005, Molecular genetics and metabolism.

[12]  S. Withers,et al.  Crystal structure of beta-D-xylosidase from Thermoanaerobacterium saccharolyticum, a family 39 glycoside hydrolase. , 2003, Journal of molecular biology.

[13]  C. Scriver,et al.  The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.

[14]  H. Scott,et al.  Mutations among Italian mucopolysaccharidosis type I patients , 1997, Journal of Inherited Metabolic Disease.

[15]  Ben M¿rad,et al.  Le choix matrimonial en Tunisie est-il transmissible? , 2004 .

[16]  G. Uziel,et al.  Molecular analysis of 30 mucopolysaccharidosis type I patients: evaluation of the mutational spectrum in Italian population and identification of 13 novel mutations , 2002, Human mutation.

[17]  C. Beesley,et al.  Mutational analysis of 85 mucopolysaccharidosis type I families: frequency of known mutations, identification of 17 novel mutations and in vitro expression of missense mutations , 2001, Human Genetics.

[18]  S. Laradi,et al.  Etude clinico-biologique et moléculaire des mucopolysaccharidoses en Tunisie du centre et du sud , 2001 .

[19]  S. Laradi,et al.  [Clinico-biologic and molecular study of mucopolysaccharidosis in central and southern Tunisia]. , 2001, Annales de biologie clinique.

[20]  P. Nabet,et al.  Mucopolysaccharidosis type I: characterization of a common mutation that causes Hurler syndrome in Moroccan subjects , 1999, Annals of human genetics.

[21]  J. Nelson,et al.  Incidence of the mucopolysaccharidoses in Northern Ireland , 1997, Human Genetics.

[22]  L. Shaffer,et al.  Spectral karyotyping refines cytogenetic diagnostics of constitutional chromosomal abnormalities , 1997, Human Genetics.

[23]  H. Scott,et al.  Molecular genetics of muccpolysaccharidosis type I: Diagnostic, clinical, and biological implications , 1995 .

[24]  C. P. Morris,et al.  Molecular genetics of mucopolysaccharidosis type I: diagnostic, clinical, and biological implications. , 1995, Human mutation.

[25]  E. Schwinger,et al.  Mucopolysaccharidosis type I: Identification of 13 novel mutations of the α‐L‐iduronidase gene , 1995 .

[26]  E. Schwinger,et al.  Mucopolysaccharidosis type I: identification of 13 novel mutations of the alpha-L-iduronidase gene. , 1995, Human mutation.

[27]  C. P. Morris,et al.  Mucopolysaccharidosis type I: identification of 8 novel mutations and determination of the frequency of the two common alpha-L-iduronidase mutations (W402X and Q70X) among European patients. , 1994, Human molecular genetics.

[28]  C. P. Morris,et al.  Multiple polymorphisms within the alpha-L-iduronidase gene (IDUA): implications for a role in modification of MPS-I disease phenotype. , 1993, Human molecular genetics.

[29]  C. P. Morris,et al.  Structure and sequence of the human α-l-iduronidase gene , 1992 .

[30]  H. Scott,et al.  α‐L‐iduronidase mutations (Q70X and P533R) associate with a severe Hurler phenotype , 1992 .

[31]  C. P. Morris,et al.  Structure and sequence of the human alpha-L-iduronidase gene. , 1992, Genomics.

[32]  C. P. Morris,et al.  A common mutation for mucopolysaccharidosis type I associated with a severe Hurler syndrome phenotype , 1992, Human mutation.

[33]  C. P. Morris,et al.  Human alpha-L-iduronidase: cDNA isolation and expression. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[34]  J. Hopwood,et al.  A fluorometric assay using 4-methylumbelliferyl α-l-iduronide for the estimation of α-l-iduronidase activity and the detection of Hurler and Scheie syndromes , 1979 .

[35]  J. Hopwood,et al.  A fluorometric assay using 4-methylumbelliferyl alpha-L-iduronide for the estimation of alpha-L-iduronidase activity and the detection of Hurler and Scheie syndromes. , 1979, Clinica chimica acta; international journal of clinical chemistry.

[36]  R. Giugliani,et al.  The mucopolysaccharidoses. , 1976, Journal of medical genetics.